There's Reason For Concern Over Bafna Pharmaceuticals Limited's (NSE:BAFNAPH) Price - simplywall.st
2 weeks ago • Google News
Bafna Pharmaceuticals Limited (BAFNAPH)
NSEINR 89.024.18%
Price Chart
Key Statistics
Market Cap
INR 2.1B
P/E Ratio
49.60
Revenue (TTM)
INR 1.46B
Volume
9.92K
52W High
INR 94.99
52W Low
INR 69.00
Dividend Yield
0.00%
Beta
0.12
Technicals
50-Day MA
77.5596
200-Day MA
78.7657
52 Week High
94.99
52 Week Low
69
About BAFNAPH
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and intern.
Employees
N/A
Headquarters
Chennai, India
CEO
Mr. Bansilal Mahaveer Chand Bafna
Latest News
Bafna Pharmaceuticals Submits Annual SEBI Disclosure - TipRanks
3 weeks ago • Google News
Bafna Pharmaceuticals Announces Board and Committee Restructuring - TipRanks
3 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg